资讯

Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
Eli Lilly (LLY) stock in focus as Texas sues the company for alleged bribery related to weight loss drugs like Zepbound and ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
Eli Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.
Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced better weight-loss results and fewer side effects.
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
Medicare covers weight loss drugs including Ozempic under specific conditions when the drug also has potential use cases beyond weight loss.
Doctors suggest that anybody with a Body mass index of over 30 or greater than 27 is advised to try weight loss drugs.
FOR years, Emma Morris hid from cameras, avoided mirrors and felt like a prisoner in her own body because of her weight. But ...